Media
Back
Under the guidance of Dr David Ho, an AIDS Institute based at the Faculty of Medicine of HKU, will be established with the objective of preventing a larger epidemic in Asia by conducting basic and applied research on HIV, create and design new therapies for the infection and, foremost, develop AIDS vaccines for China and the world.
Many Asian countries, particularly China, are experiencing rapidly increasing numbers of HIV infections. According to Chinese government officials, China has around 850,000 people infected with HIV. During the first half of 2001, the number of infections reported has risen by 67% when compared to the same period in 2000. If measures are not taken to stop the spread of the disease, the current epidemic in China could reach 10 million by the end of the decade according to a United Nations report released last week.
The AIDS Institute aims to serve as the focal point for a major Chinese Project to develop an AIDS vaccine and could provide expert advice to China and other Asian nations concerning AIDS. In collaboration with the Chinese Academy of Medical Sciences and the Yunnan Centers for Disease Control, Dr Ho's research team is already working with a package of complementary vaccines to be used in concert to build the body's defenses against HIV. Phase I clinical trials will be conducted in New York City, and discussions for testing in China are ongoing with the collaborators in Beijing and Yunnan as well as the Chinese State Drug Administration.
The AIDS Institute at HKU, in collaboration with ADARC, will present a unique resource to China to address a health problem of enormous magnitude and will present the HKSAR government with an opportunity to lead the way in addressing a possible national/international crisis.
For media enquiries, please contact Miss Polo Leung at HKU's External Relations Office (tel: 2859 2600).
AIDS Institute at HKU
05 Jul 2002
Mr Tung Chee Hwa, the Chief Executive of the Government of the Hong Kong Special Administrative Region today met with Dr David Ho, Director of the Aaron Diamond AIDS Research Centre (ADARC), and affiliate of the Rockefeller University of New York, Dr Victor Fung, Council Chairman of the University of Hong Kong (HKU), Mr Henry H L Fan, Treasurer of HKU, Professor Ian Davies, Vice-Chancellor of HKU, Mr Christopher W C Cheng, Council member of HKU, Professor Tsui Lap-Chee, Vice-Chancellor Designate of HKU and Professor S K Lam, Dean of HKU's Faculty of Medicine, and congratulated ADARC and HKU for their agreement to establish an AIDS Institute at HKU as a sister institution to ADARC. Dr David Ho and Professor Ian Davies have earlier signed a memorandum of understanding on this collaborative project.
Under the guidance of Dr David Ho, an AIDS Institute based at the Faculty of Medicine of HKU, will be established with the objective of preventing a larger epidemic in Asia by conducting basic and applied research on HIV, create and design new therapies for the infection and, foremost, develop AIDS vaccines for China and the world.
Many Asian countries, particularly China, are experiencing rapidly increasing numbers of HIV infections. According to Chinese government officials, China has around 850,000 people infected with HIV. During the first half of 2001, the number of infections reported has risen by 67% when compared to the same period in 2000. If measures are not taken to stop the spread of the disease, the current epidemic in China could reach 10 million by the end of the decade according to a United Nations report released last week.
The AIDS Institute aims to serve as the focal point for a major Chinese Project to develop an AIDS vaccine and could provide expert advice to China and other Asian nations concerning AIDS. In collaboration with the Chinese Academy of Medical Sciences and the Yunnan Centers for Disease Control, Dr Ho's research team is already working with a package of complementary vaccines to be used in concert to build the body's defenses against HIV. Phase I clinical trials will be conducted in New York City, and discussions for testing in China are ongoing with the collaborators in Beijing and Yunnan as well as the Chinese State Drug Administration.
The AIDS Institute at HKU, in collaboration with ADARC, will present a unique resource to China to address a health problem of enormous magnitude and will present the HKSAR government with an opportunity to lead the way in addressing a possible national/international crisis.
For media enquiries, please contact Miss Polo Leung at HKU's External Relations Office (tel: 2859 2600).
Facebook 
HKU IOS App 
HKU Android App 
Social Media and Apps